1 |
Akbulut, H., Zhang, L., Tang, Y. and Deisseroth, A. : Cytotoxic effect of replication-competent adenoviral vectors carrying Lplastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon. Cancer Gene Ther. 10, 388 (2003).
DOI
ScienceOn
|
2 |
Akbulut, H., Tang, Y., Maynard, J., Zhang, L., Pizzorno, G. and Deisseroth, A. : Vector targeting makes 5-fluorouracil chemotherapy less toxic and more effective in animal models of epithelial neoplasms. Clin. Cancer Res. 10, 7738 (2004).
DOI
ScienceOn
|
3 |
Graham, F. L. and Prevec, L. : Manipulation of adenovirus vectors, Methods in molecular biology, Vol. 7, pp. 109-128. E. J. Murray, The Human Press Inc., Clifton, NJ (1991).
|
4 |
Alemany, R., Balagu, C. and Curiel, D. T. : Replicative adenoviruses for cancer therapy. Nature Biotechnol. 18, 723 (2000).
DOI
ScienceOn
|
5 |
Heise, C. and Kirn, D. H. : Replication-selective adenoviruses as oncolytic agents. J. Clin. Invest. 105, 847 (2000).
DOI
ScienceOn
|
6 |
Jung, K., Kim, S., Lee, K., Kim, C. and Chung, I. : Cytotoxic effect of a replication-incompetent adenoviral vector with cytosine deaminase gene driven by L-plastin promoter in hepatocellular carcinoma cells. Arch. Pharm. Res. 30, 770 (2007).
DOI
|
7 |
Chung, I., Schwartz, P. E., Crystal, R. G., Pizzorno, G., Leavitt, J. L. and Deisseroth, A. B. : Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells. Cancer Gene Ther. 6, 99 (1999).
DOI
ScienceOn
|
8 |
Chung, I. and Deisseroth, A. B. : Recombinant adenoviral vector containing tumor-specific L-plastin promoter fused to cytosine deaminase gene as a transcription unit : generation and functional test. Arch. Pharm. Res. 27, 633 (2004).
DOI
|
9 |
Lin, C.-S., Park, T., Chen, Z. P. and Leavitt, J. L. : Human plastin genes. J. Biol. Chem. 268, 2781 (1993).
|
10 |
Lin, C.-S., Chen, Z. P., Park, T., Ghosh, K. and Leavitt, J. : Characterization of the human L-plastin gene promoter in normal and neoplastic cells. J. Biol. Chem. 268, 2793 (1993).
|
11 |
Peng, X. Y., Won, J. H., Rutherford, T., Fujii, T., Zelterman, D., Pizzorno, G., Sapi, E., Leavitt, J., Kacinski, B., Crystal, R., Schwartz, P. and Deisseroth, A. : The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines. Cancer Res. 61, 4405 (2001).
|
12 |
Chung, I. : Chemosensitization of human ovarian carcinoma cells by a recombinat adenoviral vector containing L-plastin promoter fused to cytosine deaminase transcription unit. J. Applied Pharmacol. 13, 143 (2005).
|
13 |
Zhang, L., Akbulut, H., Tang, Y., Peng, X., Pizzorno, G., Sapi, E., Manegold, S. and Deisseroth, A. : Adenoviral vectors with E1A regulated by tumor-specific promoters are selectively cytolytic for breast cancer and melanoma. Mol. Ther. 6, 386 (2002).
DOI
ScienceOn
|
14 |
Chung, I. : Cytolytic Effects of an adenoviral vector containing L-plastin promoter regulated E1A in hepatocellular carcinoma cells. J. Applied Pharmacol. 14, 148 (2006).
|
15 |
Chung, I. : Cancer gene therapgy: history and major developments. J. Toxicol. Pub. Health 19, 247 (2003).
|